Millipore Names New VP of Life Science Business Unit
John Sweeney to focus on technology development and partnerships
Sweeney joined Millipore in 2003 as Director of Strategy and Corporate Development. In that role, he was responsible for long range strategic planning and served as the lead on execution of key M&A and partnership transactions, including Millipore’s $1.4 billion acquisition of Serologicals.
In his most recent role, Sweeney transformed Millipore's web presence, generating double-digit growth. He also built the Bioscience Business Development team which has resulted in several innovation partnerships and the acquisitions of Guava and Epitome.
Sweeney is a graduate of the University of Pennsylvania and earned a Master of Business Administration degree from the Tuck School of Business at Dartmouth.
Most read news
Other news from the department people
These products might interest you
Milli-Q® Services / MyMilli-Q™ by Merck Life Science
Services & Support for Water Purification Systems
Quality Care, Delivered. In Person & Online
Good Weighing Practice by Mettler-Toledo
Your Concrete Weighing Quality Assurance Plan
GWP Verification service
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.